Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity

NCT05713799 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

NIH

Sponsor class

Conditions

Insulin Resistance
Obesity

Interventions

DRUG: Alpha-lipoic acid
DRUG: Mirabegron
DRUG: Placebo

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)